<div id="readability-page-1"><div><p>Certain A Shares of Huaxia Eye Hospital Group Co.,Ltd. are subject to a Lock-Up Agreement Ending on 7-NOV-2025. These A Shares will be under lockup for 1109 days starting from 25-OCT-2022 to 7-NOV-2025.</p><p>  Details:<br/> The Company?s actual controller Su Qingcan and person acting in concert Su Shihua committed: to not transfer or entrust to a third party the Company?s shares they hold directly or indirectly before the issuance, or allow the company to repurchase those shares within 36 months from the listing date. If within 6 months after the listing, the closing price of the shares is lower than the issuance price for 20 consecutive trading days or if the trading price is lower than the issuance price 6 months after listing, the lock-up period will be automatically extended for another 6 months. <br/> After the lock-up has expired, while holding office, they committed to not transfer more than 25% of shares held each year. </p><p>  The Company?s shareholder Huaxia Medical Investment (Xiamen) Co., Ltd. committed: to not transfer or entrust to a third party the Company?s shares they hold directly or indirectly before the issuance, or allow the company to repurchase those shares within 36 months from the listing date.</p><p>  The Company?s directors, supervisors, and senior management Chen Fengguo, Wang Qian, Huang Niya, Zhang Xiulian, Peng Jing, Li Xiaofeng, Zhang Hongtao, Chen Luyan, Cao Nai?en committed: to not transfer or entrust to a third party the Company?s shares they hold directly or indirectly before the issuance, or allow the company to repurchase those shares within 12 months from the listing date. If within 6 months after the listing, the closing price of the shares is lower than the issuance price for 20 consecutive trading days or if the trading price is lower than the issuance price 6 months after listing, the lock-up period will be automatically extended for another 6 months.</p><p>  After the lock-up has expired, while holding office, they committed to not transfer more than 25% of shares held each year.</p><p>The Company?s shareholders Xiamen Hanwei Equity Investment Partnership Enterprise (Limited Partnership), Panmao (Shanghai) Investment Center (Limited Partnership), Qilu (Xiamen) Equity Investment Partnership Enterprise (Limited Partnership), Xiamen Hongfu Equity Investment Partnership Enterprise (Limited Partnership), Xiamen Haoyun Equity Investment Partnership Enterprise (Limited Partnership), Xiamen Lukai Equity Investment Partnership Enterprise (Limited Partnership), Xiamen Bokai Equity Investment Partnership Enterprise (Limited Partnership), Xiamen Songsheng Equity Investment Partnership Enterprise (Limited Partnership), Shenzhen Qianhai Huaize Fangzhou Venture Capital Enterprise (Limited Partnership), Zhang Meichang, Li Xin committed: to not transfer or entrust to a third party the Company?s shares they hold directly or indirectly before the issuance, or allow the company to repurchase those shares within 12 months from the listing date.</p></div></div>

華廈眼科

<p>華廈眼科醫院集團有限公司的部分 A 股在鎖定協議下，直到 2025 年 11 月 7 日，鎖定期為 1109 天，從 2022 年 10 月 25 日開始。包括實際控制人在內的關鍵利益相關者和各類股東已承諾在上市後的一定期限內不轉讓其股份。如果股價連續交易日低於發行價，鎖定期可能會延長。鎖定期結束後，他們每年只能轉讓 25% 的股份</p>

華廈眼科醫院集團股份有限公司的部分 A 股受到鎖定協議的限制，該協議將於2025年11月7日到期